Growth hormone therapy in achondroplasia
Copyright policy )Growth hormone therapy in achondroplasia
The status of growth hormone (GH) secretion together with the effect of GH therapy was studied in six children with achondroplasia. One patient had impaired GH secretion, which may, in part, be due to obesity. The pre-GH-treatment height velocity was 3.8±0.7 cm/year, but this increased to 6.0±1.0 cm/year in the first year of treatment and to 4.4±0.6 cm/year in the second year. One patient who underwent GH therapy for 4 years showed good response in height velocity. A considerable variation was observed in response to GH therapy within the treated cases.
Male, Heart Ventricles, Growth, Body Height, Achondroplasia, Child, Preschool, Growth Hormone, Humans, Female, Foramen Magnum, Obesity, Insulin-Like Growth Factor I, Child, Follow-Up Studies
Male, Heart Ventricles, Growth, Body Height, Achondroplasia, Child, Preschool, Growth Hormone, Humans, Female, Foramen Magnum, Obesity, Insulin-Like Growth Factor I, Child, Follow-Up Studies
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).16 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!